GMED
Globus Medical, Inc.
NYSE · Healthcare · Medical - Devices · US
$78.58
+0.59%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
15.4x
EV/EBITDA
11.5x
Market Cap
$10.55B
MomentumView details →
1D Return
+0.59%
YTD Return
−10.35%
RSI (14)
38.0
ValuationView details →
P/E (Fwd)
15.4x
EV/EBITDA
11.5x
Market Cap
$10.55B
RSI (14)
38.0
MomentumView details →
1D Return
+0.59%
YTD Return
−10.35%
SummaryUpdated Jun 1, 2026
Globus Medical, Inc. (NYSE:GMED) is a medical device company founded in 2003 and headquartered in Audubon, Pennsylvania. The company went public in 2012 and has grown through both organic expansion and strategic acquisitions to become a major player in the musculoskeletal medical device market. In September 2023, Globus completed a transformative merger with NuVasive, significantly expanding its product portfolio and global reach. The company has evolved from a spine-focused specialist into a comprehensive musculoskeletal solutions provider, offering products for spine, trauma, orthopedics, and enabling technologies including robotic surgical systems.
Similar companies
Latest newsMore news →
Globus Medical announced CE Mark approval for its Excelsius3D imaging system, expanding its Excelsius ecosystem in the European Union.23h agoGlobus Medical, Inc. announced the acquisition of Higgs Boson Health, a digital healthcare experience company based in Durham, NC and incubated out of Duke University, to transform healthcare experience through AI-driven digital solutions.9d ago